• Skip to primary navigation
  • Skip to main content
  • Skip to footer

Chemical Glycobiology: Study of Glycans and the Immune System

Transcript of Part 2: Imaging the Glycome

00:00:06.26		So welcome to the second lecture in the series
00:00:09.00		called Chemical Glycobiology.
00:00:11.07		My name is Professor Carolyn Bertozzi.
00:00:13.26		I am in the department of Chemistry at UC Berkeley,
00:00:17.21		with also an appointment in Molecular and Cell Biology Department
00:00:21.11		and I am also an investigator of the Howard Hughes Medical Institute.
00:00:25.06		I.. This is the second part of a two part series.
00:00:28.23		The first part focused on the background and history
00:00:32.09		about the field of glycobiology and the structures of sugars.
00:00:36.18		And this part, which is part two, is going to focus more
00:00:40.26		on some recent research from my own laboratory at Berkeley
00:00:43.25		with the goal towards imaging the glycome.
00:00:46.18		And in fact, what you are looking at here is
00:00:49.07		a fluorescence image of a zebrafish
00:00:53.06		that's five days old in which some of the sugars have been tagged
00:00:57.24		with fluorescent molecules and this allows us to literally visualize those sugars
00:01:02.18		in a live organism. And so let me tell you about
00:01:06.15		why we are interested in that.
00:01:08.03		Okay, now the field of molecular imaging is certainly large
00:01:13.15		and expanding rapidly, and it's very important
00:01:16.28		both from the perspective of clinical medicine
00:01:19.15		as well as in the research laboratory.
00:01:22.15		So many of you might have found yourself lying on a table like this
00:01:26.14		at one point in your lives, as have I.
00:01:29.05		This is a magnetic resonance imaging scanner, or a MRI scanner
00:01:34.24		and what this scanner can do
00:01:36.26		is literally take a picture of molecules
00:01:39.29		inside our bodies without having to cut us open.
00:01:42.24		Which is very convenient for many of us.
00:01:44.26		And there are devices very similar to this one which allow
00:01:49.13		clinicians to look at other molecules in our bodies,
00:01:52.00		molecules that are radiolabeled for example.
00:01:54.15		And that is what this image is here.  This is called a PET scan.
00:01:59.00		of a human body that has been injected with a radiolabeled version of glucose.
00:02:04.02		Now these are important tools for looking at molecules in clinical settings.
00:02:09.28		but we also like to look at molecules in research settings
00:02:12.16		particularly to understand what molecules are doing inside
00:02:16.02		living cells and nowadays we have some wonderfully advanced
00:02:20.06		fluorescence microscopy tools
00:02:22.10		that allow us not just to see the collections of molecules in cells,
00:02:26.12		but individual fluorescent molecules as well.
00:02:29.12		So it's a very exciting time to be doing molecular imaging in living systems.
00:02:34.24		Now, I mentioned in my first lecture that one of the most
00:02:38.29		intriguing aspects of glycobiology is the fact that
00:02:43.15		the glycome or the complete collection of glycans that a cell makes
00:02:48.09		is dynamic. It's not fixed.
00:02:50.19		So, the glycome, or the collection of sugars on the surface of a cell
00:02:55.21		when it's in one particular state
00:02:57.12		is different from the collection of sugars on that same cell
00:03:00.27		when the cell has transformed its state.
00:03:04.02		This is certainly the case when embryonic stem cells
00:03:07.11		choose a differentiation fate
00:03:10.00		and then become a differentiated cell,
00:03:12.09		like a muscle cell, or a neuron. If you look at the collection of
00:03:16.02		the glycans on the cell surface glycolipids and glycoproteins,
00:03:20.03		you'll find that the nature of that collection has changed
00:03:23.01		as the cell has undergone a differentiation process.
00:03:26.12		From the perspective of clinical medicine,
00:03:30.07		it's interesting to note that the glycome changes when healthy cells
00:03:34.18		transform and become cancer cells.
00:03:37.28		So, you can understand if the sugars on the surface of the cell
00:03:42.02		are changing in a manner that is characteristic of a cancerous state,
00:03:46.06		it would be very convenient if we could actually see
00:03:49.19		those sugars change in vivo, in living human beings.
00:03:54.10		Because that would offer the possibility of imaging those changes
00:03:58.15		and detecting cancers when they are at hopefully very early stages.
00:04:02.17		So there are many reasons why one would want to image the glycome,
00:04:07.11		to take a look at how those sugars are changing inside living subjects.
00:04:12.00		So we can understand how do the glycans relate to differentiation of cells
00:04:17.06		or to organogenesis. And can we detect changes in the glycome
00:04:22.20		that correlate with disease states.
00:04:24.23		So that we can detect those diseases at very early stages.
00:04:29.11		The challenge, of course, is to figure out how to tag these sugar molecules with
00:04:35.14		probes that we can actually visualize using imaging technologies.
00:04:40.16		So even in the research laboratory, this is very challenging.
00:04:43.22		The most commonly used imaging technique in research laboratories
00:04:48.05		is fluorescence imaging, or optical imaging.
00:04:51.02		And we don't even have a way to put fluorescent tags
00:04:55.02		on these sugars. So that is a challenge
00:04:57.24		that students and postdoctoral fellows
00:05:00.02		in my laboratory have taken on.
00:05:03.09		And it's a project we started working on back in the late 1990's.
00:05:07.08		So it's been progressing now for over ten years.
00:05:09.21		Just to give you a little bit of counterpoint,
00:05:12.17		people who study proteins using molecular imaging techniques,
00:05:16.22		have a wonderful arsenal of tools available to them,
00:05:20.18		which is why images like the one I showed on the previous slide
00:05:24.06		are so common and so familiar.
00:05:26.23		to most cell biologists. In fact,
00:05:28.15		most cell biologists probably spend a good portion of their day
00:05:31.22		looking at images similar to this one.
00:05:34.06		In this cell two different proteins have been labeled
00:05:37.14		with two different fluorescent dyes,
00:05:39.28		one green and one red.
00:05:40.24		And the protein that appears green has been labeled using a genetically encoded reporter.
00:05:47.03		So let me just show you what that reporter is.
00:05:49.15		It is called the green fluorescent protein,
00:05:52.19		abbreviated GFP, and it's one of the most important tools for fluorescence imaging
00:05:59.21		of proteins. The green fluorescent protein, because it's a protein that is encoded by a gene,
00:06:05.01		and it turns out that one can fuse the gene that encodes GFP
00:06:08.20		to the gene that encodes the protein that you are interested in imaging.
00:06:12.19		And now, when the GFP protein fusion is expressed,
00:06:17.14		basically your protein of interest is labeled with a fluorescent molecule.
00:06:21.08		The GFP has a chromophore inside that is fluorescent.
00:06:25.09		And this is such an important tool.  It's revolutionized our abilities
00:06:31.08		to study proteins, not just in live cells, but even in transgenic organisms.
00:06:35.19		which we express these GFP-fusions by manipulating the genome
00:06:40.20		in the embryonic stem cell stage.
00:06:42.22		This is so important that it was recognized with the Nobel Prize in Chemistry
00:06:47.03		in the year 2008, and that prize was granted to these three scientists.
00:06:52.00		Very well deserved. Very exciting development
00:06:54.23		in the field of molecular imaging.
00:06:56.22		Now those of us who study glycobiology, of course,
00:07:01.09		would love it if we had a tool that was comparable
00:07:04.12		to the green fluorescent protein.
00:07:05.28		So that we could label our sugars with a fluorescent tag,
00:07:09.05		the way that people label proteins with this fluorescent tag.
00:07:12.16		But unfortunately the biosynthetic machinery,
00:07:17.17		by which sugars are built, doesn't really lend itself
00:07:21.02		to these genetically encoded reporters.
00:07:23.09		That's because sugars, unlike proteins, are not primary gene products.
00:07:28.21		Each of these complex glycans is not encoded by a single gene.
00:07:33.17		Rather, they are the products of a complex series of
00:07:38.26		metabolic steps inside the cell.
00:07:41.02		They are products of metabolism.
00:07:43.21		And so for that reason, we cannot use genetically encoded reporters like GFP
00:07:48.02		to introduce labels onto sugars.
00:07:50.17		So I drew this cartoon as kind of some comedy, because we would love
00:07:54.24		to be able to put a tag like GFP on the sugars,
00:07:57.18		but there is really no mechanism to do that using genetics.
00:08:01.11		So, in my laboratory, we have been focusing
00:08:04.21		on using the metabolic pathways of the cell.
00:08:08.22		to introduce fluorescent probes into the sugars
00:08:12.12		that are not the GFP but rather small molecule fluorescent reporters.
00:08:17.18		And let me show you schematically how we go about doing this.
00:08:21.22		It's a two-step process, and we call this metabolic labeling of glycans
00:08:27.14		with chemical reporters.
00:08:29.15		The first step is to feed cells a synthetic
00:08:33.14		monosaccharide building block
00:08:35.17		Now this synthetic sugar looks very much like one of the natural
00:08:40.08		monosaccharide building blocks that you might find
00:08:43.06		in foods that you eat, and I introduced those structures in my first lecture.
00:08:47.26		But the difference is that we have altered the structure
00:08:51.07		of this monosaccharide building block to introduce
00:08:54.22		a chemical functional group "X"
00:08:57.14		and "X" is just the generic for now,
00:08:59.08		and in a minute we will get to what that is.
00:09:00.23		But "X" is what we call the chemical reporter.
00:09:04.17		It's a reactive functional group
00:09:07.05		so that when the cell takes this monosaccharide
00:09:10.18		building block, and when the enzymes process it and integrate it into the glycans,
00:09:15.29		when the glycan appears on the cell surface, that reactive functional group
00:09:20.07		is now on display and can be used in a second step
00:09:24.09		which is a chemical reaction with a probe molecule.
00:09:27.25		Now the probe is a fluorescent dye, for example.
00:09:31.18		And that probe has its own chemical functional group, let's call it "Y".
00:09:35.10		just as a generic label. But "X" and "Y" have to be designed
00:09:40.15		so they react with each other to form a bond.
00:09:43.29		And once that bond is formed
00:09:45.17		now there is a fluorescent probe molecule
00:09:49.20		bound to a cell surface glycan.
00:09:53.07		And that probe now allows us to visualize all of the glycans
00:09:57.01		that possess this red monosaccharide
00:09:59.17		building block as one of their constituents.
00:10:01.29		So, this is a very straightforward schematic
00:10:05.19		in that what we need to do is feed the cell a modified sugar
00:10:09.15		and then do a chemical reaction on that sugar
00:10:12.27		once it's been displayed on the cell surface with a probe.
00:10:15.21		But it turned out that there was a very significant chemical challenge.
00:10:20.08		embedded in this problem because we have to select
00:10:24.03		the chemical reporter "X" and a complementary functional group "Y",
00:10:29.09		so that these two functional groups react
00:10:33.00		only with each other and not with anything else inside this cell.
00:10:38.25		And let me tell you, there is a lot of functionality inside this cell.
00:10:43.21		All of your proteins and your lipids, your nucleic acids,
00:10:47.15		metabolites, there's water, you know, there are a lot of chemical entities inside this cell
00:10:53.27		and "X" and "Y" have to be designed to avoid any side reaction
00:10:58.26		with those biological groups and still react only with each other.
00:11:03.14		So that was a pretty significant challenge
00:11:06.11		and we embodied that concept of that challenge
00:11:09.12		with this term "bioorthogonal".
00:11:12.29		So, what this means literally is not interacting with biology.
00:11:18.07		"X" and "Y" have to react mutually and selectively with each other.
00:11:22.10		They cannot react with anything
00:11:24.07		that's found in nature. And of course, they certainly cannot be harmful
00:11:28.09		to the biological system under study
00:11:30.25		otherwise that would be a disaster from the perspective of
00:11:34.10		imaging sugars in live animals.
00:11:36.15		So we spent many years trying to craft reactions that
00:11:42.24		basically fit this description where the two
00:11:45.27		reactive counterparts, X and Y, are bioorthogonal.
00:11:50.03		And to make a long story short, what we discovered is that
00:11:55.14		an ideal chemical reporter, the group X that we put inside the sugar
00:12:00.16		is the azide, which is defined as having
00:12:04.12		three nitrogen atoms linked to each other
00:12:06.10		in a manner that is shown here.
00:12:08.26		Now the azide has a number of properties that make it very well suited
00:12:14.04		for this particular application as a chemical reporter.
00:12:17.04		First and foremost, azides are not found in biological systems.
00:12:22.03		As far as we know chemists invented the azide.
00:12:26.06		We have not found it in nature.
00:12:27.25		Maybe nature overlooked this functional group
00:12:29.27		when she was creating all of the chemical
00:12:32.21		diversity that's found on our planet.
00:12:34.22		Furthermore, azides are essentially inert in biological systems.
00:12:39.29		There's really not much that they can react with
00:12:41.22		that is normally found in a biological environment.
00:12:45.22		Azides are very easy to attach to sugar molecules.
00:12:50.14		The chemistry is very simple.
00:12:52.05		And importantly, azides are small.
00:12:54.12		So the van der Wahl's radius of an azide is only about 2.4 Angstroms.
00:12:59.22		Which means that it is just a little bit larger than a methyl group.
00:13:03.08		And that's important because we are attaching an azide to a sugar
00:13:08.11		and then asking all of the enzymes
00:13:09.23		inside the cell to metabolize that sugar as if
00:13:12.17		it were a normal metabolic substrate.
00:13:15.14		And so we can't change the structure too much,
00:13:18.12		otherwise those enzymes might reject
00:13:21.06		that sugar as being too foreign, too unnatural.
00:13:23.25		But the azide is a pretty small modification.
00:13:26.19		We thought maybe we could sneak it through the door.
00:13:28.18		of some of those enzymes.
00:13:31.01		Let me just make a point because
00:13:33.08		I am asked this question frequently
00:13:34.20		amongst biologists.  Many biologists are familiar with the word azide
00:13:40.08		in the context of sodium azide
00:13:42.13		and they know sodium azide to be a metabolic poison.
00:13:46.27		They often put a little bit of sodium azide into their buffers
00:13:51.01		to prevent bacterial growth. So they know that sodium azide is cytotoxic.
00:13:55.08		and therefore they ask me, "Aren't azides cytotoxic?
00:13:59.04		How can you put an azide on a sugar
00:14:00.18		and feed it to cells and feed it to organisms? Isn't that toxic?"
00:14:03.24		The answer is no. Sodium azide is a very different entity
00:14:08.11		from azides attached to a molecule.
00:14:11.14		So once the azide is attached to a molecule like a sugar,
00:14:14.19		it's totally harmless. By contrast, if azide is a salt like sodium azide,
00:14:20.02		you are right, then it is very toxic.
00:14:21.25		But we don't actually have to worry about that.
00:14:24.01		because there is no way in your body to convert a sugar azide
00:14:28.03		to something like sodium azide.
00:14:30.14		So, don't worry about that.
00:14:31.24		Okay. Now what's most important about the azide
00:14:35.16		is that the azide can undergo chemical
00:14:38.20		reactions with other functional groups
00:14:41.12		which remember in the previous slide I called those Y.
00:14:44.06		The other group is Y. This group is X.
00:14:46.18		There are several different Y groups that will react with azides.
00:14:50.27		And the first such group that we explored
00:14:54.03		is a phosphine. So a phosphine is what you get when you take a phosphorus atom
00:14:59.18		and you link three substituents to it like I've shown here.
00:15:03.25		Now back in the early part of the 20th century.
00:15:07.27		We are talking around 1915 to 1920,
00:15:11.12		a German chemist by the name of Hermann Staudinger
00:15:14.28		discovered that phosphines will react with azides to generate
00:15:20.17		a product in which there is a phosphorus-nitrogen bond
00:15:24.08		and he called this kind of an intermediate an aza-ylide.
00:15:27.19		It's a very interesting reaction in that these
00:15:30.22		two chemical groups join together and make this covalent
00:15:34.22		adduct.  We were intrigued by this Staudinger chemistry
00:15:38.29		because both phosphines and azides are bioorthogonal
00:15:43.08		and their reaction is very selective. They are very non-toxic.
00:15:47.27		And it seemed to fulfill many of these criteria for bioorthogonality.
00:15:52.07		With one exception.  It turns out that aza-ylides
00:15:55.16		are not particularly stable in water.
00:15:58.00		They tend to hydrolyze.
00:16:01.05		So the P-N bond gets cleaved.
00:16:03.00		And of course, if our goal is to use the chemistry
00:16:05.22		to attach a probe to a sugar in the living body
00:16:09.10		where we are surrounded by water
00:16:12.09		then that hydrolytic sensitivity would be a major problem for an aza-ylide.
00:16:17.01		So what we did was we modified this reaction in a fairly subtle way
00:16:22.19		where we attached to the phosphorus atom a benzene ring
00:16:26.18		that had this methoxycarbonyl group.
00:16:29.01		So now, once the aza-ylide was formed
00:16:32.18		faster than it could hydrolyze, this nitrogen atom
00:16:35.16		cyclized to this carbonyl, cleaved the ester bond,
00:16:39.18		and formed an amide.
00:16:41.29		And this cyclization was so fast that it didn't
00:16:45.04		even matter whether there was water around.
00:16:47.09		Now once this product was formed,
00:16:49.08		water could come along at its leisure
00:16:51.15		hydrolyzed the P-N bond and form this product, but now, because an amide
00:16:56.28		bond had formed during this intramolecular cyclization step
00:17:01.04		these two parts, one that came from the azide
00:17:04.00		the other attached to the phosphine
00:17:06.14		were still linked together through a very stable linkage.
00:17:09.09		So this is what we call the Staudinger ligation.
00:17:13.18		It's a reaction in which we take advantage of the classic Staudinger chemistry
00:17:19.02		in the first step but then we alter it to form a product
00:17:22.20		in which the two components are permanently
00:17:24.14		ligated together in a manner that is
00:17:26.08		very stable in a biological system.
00:17:29.03		And the Staudinger ligation was one of the first
00:17:32.06		chemical reactions that we used to try to image sugars in living systems.
00:17:38.01		So which sugars would you like to image?
00:17:41.24		Of course there are many interesting choices.
00:17:44.08		And as I introduced in my first lecture,
00:17:46.24		in vertebrates there are nine
00:17:49.07		fundamental monosaccharide building blocks
00:17:52.01		that are the constituents of our various glycans.
00:17:55.04		They are all interesting in their own right,
00:17:58.01		but when we were thinking about what sugar would we like to image,
00:18:01.10		we were naturally drawn to this monosaccharide,
00:18:05.24		called sialic acid. And as I mentioned in my first lecture,
00:18:09.21		sialic acid tends to appear in some very interesting circumstances
00:18:15.08		in vertebrate biological systems.
00:18:18.12		I mentioned for example, that sialic acid
00:18:21.01		is a component of the ligand for the selectins.
00:18:24.27		I also mentioned that sialic acid
00:18:27.01		is the structure that the influenza virus binds to.
00:18:30.18		Well, it turns out that sialic acid is a pretty busy monosaccharide.
00:18:36.20		because it also seems to be related to embryonic development
00:18:40.19		and to cancer. In fact, the glycomes of embryonic cells,
00:18:46.01		differentiating tissue, as well as cancer cells
00:18:49.14		have been studied in much detail
00:18:52.15		and it turns out that many of the glycans
00:18:54.25		found both embryonically and on cancers
00:18:57.22		have sialic acid as one of their constituents.
00:19:00.19		So what I have shown here are just three examples from a much larger set.
00:19:05.03		These are glycan structures that have been found to be highly elevated
00:19:10.25		on cancers compared to the normal healthy tissue counterpart.
00:19:14.14		And many of them are also developmentally regulated.
00:19:17.29		which is probably not an accident, because we know that often cancers
00:19:22.14		start to acquire properties that we
00:19:25.12		normally associate with embryonic tissue.
00:19:27.19		They've sort of lost their identity
00:19:30.11		and they are reverting to an embryonic state.
00:19:32.23		and that's reflected in their glycan structures.
00:19:35.27		So polysialic acid which is a homo-polymer
00:19:38.28		made up of repeating units of sialic acid
00:19:41.16		is highly abundant on a variety of tumors
00:19:44.13		that are derived from neural crest tissue.
00:19:46.16		Sialyl Lewis X, which I mentioned before
00:19:50.02		is part of the ligand for the selectins,
00:19:54.02		is also found in elevated levels on a variety of different epithelial cancers.
00:19:57.08		and blood cancers. And Sialyl Tn, a very simple disaccharide,
00:20:03.12		is actually not normally found on any healthy human tissue
00:20:07.12		but it appears on a variety of prostate cancers.
00:20:11.03		and we don't really know why that is,
00:20:12.29		but the fact that these structures appear in the context of malignancies
00:20:18.06		has suggested to many people that there might be
00:20:21.03		elevated levels of sialic acids on these tissues.
00:20:25.25		So if we could image the sialic acids,
00:20:28.05		maybe we could detect these tumors in living systems.
00:20:31.25		That was one of the motivations to study the sialic acids.
00:20:35.25		Okay. So then the question became, in our minds,
00:20:39.24		how do we put an azide into the sialic acids?
00:20:43.06		Well, we have to understand the fundamental metabolism
00:20:46.22		that produces sialic acid in our body.
00:20:50.05		And that's what is shown in this slide.
00:20:52.15		It all begins with this simple monosaccharide
00:20:56.23		building block called N-acetylmannosamine.
00:21:00.08		and we abbreviate that ManNAc for short.
00:21:03.14		So you eat ManNAc and in fact if you eat bread or drink beer,
00:21:09.13		any yeast product will have some ManNAc.
00:21:11.21		If you don't eat ManNAc, that's okay
00:21:14.15		because you are able to biosynthesize it from glucose
00:21:17.21		through other enzymatic steps that I haven't shown.
00:21:20.27		But in any event, once ManNAc enters your system,
00:21:23.19		it has basically one metabolic fate.
00:21:26.15		It is destined to be converted to sialic acid.
00:21:28.27		in your cells. And that happen through a series of enzymatic steps
00:21:34.18		and I am not going to go through all these details.
00:21:37.18		You can certainly look at the slide in detail if you are interested.
00:21:40.17		But it suffices to say, that you eat this sugar
00:21:44.00		and after all of these enzymes have acted on it
00:21:46.29		at the end of the day a sialic acid is made,
00:21:50.05		and it appears usually at the end of complex glycan chain
00:21:54.19		on the surface of your cell, either in a glycoproteins or glycolipids.
00:21:58.13		So we knew from the work of many labs
00:22:01.17		that this sugar gets converted to this sugar.
00:22:04.07		And I've shown the acetyl group in blue.
00:22:08.04		So that it is clear where that ends up in the biosynthetic product.
00:22:11.28		And the reason that I highlight that acetyl group
00:22:14.12		is because we know from the work of several groups
00:22:17.27		that you can make subtle modifications
00:22:20.22		to the structure at this position without
00:22:23.14		significantly harming the efficiency of
00:22:26.13		any of these enzymatic steps,
00:22:28.06		which is really quite remarkable if you think about it.
00:22:30.23		Normally we think of enzymes as being very particular
00:22:34.18		for their substrates, but in this pathway
00:22:37.26		there is a little bit of leeway and you
00:22:39.00		can modify this side chain a little bit.
00:22:41.26		So knowing that, it was clear to us that this was a site
00:22:46.08		that we might be able to attach an azide
00:22:48.16		without confusing the enzymes in the cell.
00:22:52.01		And that's exactly what we did.
00:22:54.27		So by chemical synthesis we generate this unnatural version
00:22:59.04		of ManNAc, which has an azide.
00:23:01.21		So as an abbreviation we call this compound ManNAz,
00:23:06.04		where it is the azide version of ManNAc.
00:23:09.10		And we wanted to get ManNAz into cells, so to do that we
00:23:15.12		block each of the hydroxyl groups, which are characteristic of sugar molecules
00:23:19.29		with acetyl esters. Those are protecting groups.
00:23:24.13		So once the acetyl groups are in place the sugar is now sufficiently lipophilic
00:23:29.21		that it will penetrate through the cell's membrane, and once it is inside the cell,
00:23:35.09		we have non-specific esterases that simply cleave
00:23:38.25		these acetyl groups off and throw them away.
00:23:40.22		And then  the sugar is ready for metabolism.
00:23:43.05		So the enzymes start processing the sugar
00:23:46.11		and after several hours what we found is that,
00:23:48.15		lo and behold, some fraction of the sialic acid residues
00:23:52.07		on these cells had been replaced with an azido analog.
00:23:56.23		So in other words, all we do is add this compound to cell culture media,
00:24:01.16		and the cells do all the hard work
00:24:03.05		and they produce this azido-sialic acid on their cell surface glycans.
00:24:08.01		Remarkably the cells don't seem particularly
00:24:11.28		offended by this transformation.
00:24:13.26		Some fraction of their sialic acids
00:24:16.18		have been replaced with this unnatural variant
00:24:18.29		and that seems fine with them.
00:24:21.16		But it's very convenient for us
00:24:22.28		because now we can use the azide to do chemistry.
00:24:26.18		And so by introducing a phosphine reagent,
00:24:29.05		that's been linked to a fluorescent probe, we
00:24:32.13		do a Staudinger ligation between the phosphine and the azide.
00:24:35.10		now there's a covalent bond between the probe molecule and the sugar.
00:24:40.22		So wherever there is a sialic acid,
00:24:42.16		we can now visualize it
00:24:44.06		using fluorescence microscopy focusing on the probe.
00:24:47.12		And so in this manner we have been able to image
00:24:50.17		sialic acids on a variety of interesting cell types.
00:24:54.01		And sialic acid is not the only sugar
00:24:56.29		that we can see using the azide as a chemical reporter.
00:25:00.20		So, just as we can introduce the azide into sialic acid,
00:25:05.07		by feeding the cells ManNAz.
00:25:08.09		It turns out we can introduce an azide into fucose
00:25:11.22		simply by feeding the cells this 6-azido fucose derivative
00:25:16.23		that has acetyl esters protecting its hydroxy groups.
00:25:19.26		And likewise, we can introduce azides into N-acetylgalactosamine
00:25:25.18		or GalNAc, by feeding cells this modified form of GalNAc,
00:25:30.18		that has an azide on its acetyl group.  We call this GalNAz.
00:25:34.13		analogous to ManNAz, and I actually will be coming back to this sugar
00:25:38.20		GalNAz towards the end of the lecture.
00:25:41.10		We also put quite a bit of time into developing probes
00:25:45.16		that we can use to visualize these sugars.
00:25:49.10		Now the Staudinger ligation is wonderfully selective
00:25:51.24		in that it allows us to form a covalent bond between the probe and the sugar.
00:25:57.06		But more than that we can exploit elements
00:25:59.24		of that ligation chemistry in order to design what we call smart probes.
00:26:05.11		So these are probes that are actually invisible
00:26:08.06		until they find an azido sugar
00:26:11.28		form that bond through the Staudinger ligation,
00:26:14.13		and then they become fluorescent.
00:26:16.04		So they basically swim around in the system,
00:26:18.11		they look for azides and as soon as they find them,
00:26:20.26		they make a bond and light up, and you don't see them otherwise.
00:26:23.29		This allows us to do fluorescence imaging
00:26:26.01		with very good signal above background.
00:26:28.23		The way we do this is to exploit the fact that
00:26:32.19		during the course of the Staudinger ligation,
00:26:34.11		this ester bond will be cleaved.
00:26:36.18		In the previous slides I had simply a methyl ester at this position.
00:26:41.18		where methanol was released during the reaction
00:26:44.28		which is not particularly remarkable.
00:26:46.25		But, one could replace that methyl ester
00:26:49.00		with an ester linkage to a fluorescence quencher.
00:26:52.23		And if there is a fluorescent molecule bound elsewhere,
00:26:55.16		that fluorophore will be quenched
00:26:57.19		by the quencher in this initial molecule.
00:27:01.01		But as soon as this probe finds an azide,
00:27:03.21		located within a sialic acid, let's say, or another sugar on the cell,
00:27:08.02		the phosphine reacts with the azide
00:27:10.14		the Staudinger ligation unfolds,
00:27:13.01		the ester is cleaved, the quencher is released,
00:27:16.12		now that fluorophore is activated.
00:27:19.18		So only once the fluorophore finds its target
00:27:22.09		and reacts, only then do you see the fluorescence.
00:27:25.14		Otherwise it's invisible.
00:27:26.27		Let me show you an actual chemical structure of a probe
00:27:29.25		that we prepared that follows precisely this mechanism.
00:27:35.08		This is a molecule that we call affectionately "QPhos",
00:27:40.06		which stands for quenched phosphine.
00:27:41.22		It's got three parts to it:
00:27:44.20		so over here, this green part is a very well known
00:27:48.08		fluorescent molecule called fluorescein.
00:27:50.07		It's a green fluorescent dye commonly used in the research laboratory.
00:27:55.22		In the middle in black is a phosphine that's all set up for a Staudinger ligation.
00:28:01.29		You can see that on this benzene ring there is an ester group.
00:28:06.05		That's positioned for that intramolecular reaction
00:28:09.14		of the aza-ylide intermediate.
00:28:11.06		And then finally over here, the blue part
00:28:14.03		is a well-known fluorescence quencher,
00:28:16.23		called Disperse Red 1.
00:28:18.28		And as long as this Disperse Red 1 is linked to this ester
00:28:22.15		it will quench the fluorescence of the fluorescein molecule.
00:28:25.26		So let me show you some images that we took using QPhos
00:28:30.07		to detect sialic acid on cancer cells in culture.
00:28:35.12		So in this experiment what we did was we grew some cells
00:28:40.12		called HeLa cells. These are human cervical epithelial cancer cells
00:28:45.22		that you can grow in a test tube. And while those cells were growing,
00:28:49.13		we fed them ManNAz in the media.
00:28:53.03		We just added it to the cell culture media,
00:28:55.08		they took it up, they digested it, and they put azides into their sialic acids.
00:29:00.13		Then, after a few days of treatment with ManNAz,
00:29:03.09		we reacted those cells with QPhos.
00:29:06.22		And then after a couple of hours we took a fluorescence image of those cells.
00:29:11.13		The cells were also stained with a blue fluorescent dye
00:29:15.03		that is specific for the nucleus.
00:29:16.17		That just helps you to orient exactly where the cells are positioned
00:29:20.27		since each one has one nucleus.
00:29:22.29		So, what you can see is that each cell
00:29:25.17		is surrounded by a nice bright green outline.
00:29:29.15		Those are the sialic acids on the
00:29:32.05		membrane associated glycoproteins and glycolipids.
00:29:35.09		of the cell and they are nicely lit up.
00:29:37.25		We are actually imaging the sugars.
00:29:39.26		You might see a little bit of fluorescence inside the cells as well.
00:29:43.16		That's basically part of the secretory pathway,
00:29:47.23		the Golgi compartment for example.
00:29:49.01		And then there's a little bit of staining of
00:29:51.14		little vesicles throughout the cells as well.
00:29:53.05		That's because after we react sialic acids on the membrane
00:29:57.17		some of those sialic acids end up internalized
00:30:00.21		into vesicles because the membranes are constantly being
00:30:03.26		engulfed and recycled and turned over.
00:30:05.29		They are going back into the late part of the Golgi compartment
00:30:08.23		and then coming back to the membrane.
00:30:10.09		There's a lot going on in fact during the course of reaction with QPhos.
00:30:14.26		Now we had some issues once we started
00:30:17.29		doing these kinds of experiments.
00:30:19.07		For example, we realized that in order to get this nice bright staining
00:30:23.24		of the sialic acids, we had to react the cells with QPhos for several hours.
00:30:28.27		Now that's not a problem for imaging the sugars on cultured cells,
00:30:34.17		because the cells are in a flask with the reagents
00:30:37.26		and they can sit in the incubator for several hours.
00:30:40.12		and just let the reaction unfold.
00:30:42.09		The reason we had to let the reaction go for several hours
00:30:45.15		as opposed to several minutes
00:30:47.02		or several seconds is that it turns out the Staudinger ligation reaction
00:30:51.02		is intrinsically rather slow. It just takes that long for the reaction to proceed.
00:30:57.24		And although that was not too problematic
00:31:00.21		for imaging experiments on cultured cells,
00:31:03.25		we worried that that could be a problem
00:31:06.23		for imaging sugars in living animals.
00:31:10.09		because of course a living animal is not at equilibrium.
00:31:14.10		It is not cells in a flask sitting in an incubator for many hours.
00:31:17.26		Animals have an active metabolism.
00:31:21.04		As soon as you introduce reagents into their bodies,
00:31:24.19		their bodies are working on clearing those reagents right out again.
00:31:27.29		And that clearance process can be very rapid for certain molecules
00:31:32.18		and certain animals.  In fact, when we started looking into the Staudinger ligation
00:31:38.06		as a tool for imaging sugars in laboratory mice
00:31:41.23		we immediately ran into this problem.
00:31:44.29		So we injected mice with ManNAz
00:31:48.08		and we found that in the animal
00:31:52.03		the cells were perfectly willing to take up this sugar
00:31:54.23		and convert it to the azido-sialic acid,
00:31:58.01		that was no problem.
00:31:59.21		And it seemed harmless to the mice.
00:32:01.17		So there was no obvious detriment to replacing
00:32:04.09		some fraction of the sialic acids with the azido version.
00:32:08.00		The problem came when we then injected those same mice
00:32:11.26		with probe molecules bound to a
00:32:15.09		phosphine for the Staudinger ligation.
00:32:17.04		Because what we discovered is that the
00:32:19.24		reaction between the phosphine and the azide
00:32:21.26		was just too slow compared to the rate of metabolic clearance
00:32:25.23		of the probe out of the animal's body.
00:32:28.02		So we could only detect a little bit of this product
00:32:31.26		just on certain organs and tissues
00:32:34.00		The organs and tissues that were the most accessible
00:32:36.22		to the reagents after we injected them
00:32:38.14		or the organs and tissues that had really, really high levels
00:32:41.23		of the sialic acid we were trying to image.
00:32:45.07		And that was a little frustrating,
00:32:47.00		but it basically pointed to a very important element
00:32:50.12		of this experiment, which we really hadn't considered at the very outset.
00:32:55.07		You know, ten years ago.
00:32:56.04		Which is that the kinetics of the reaction
00:32:59.05		between the azide and the probe molecule
00:33:01.16		are very, very important for imaging in living animals.
00:33:06.02		That reaction has got to be fast enough
00:33:08.29		so that the probe can find the azide and react
00:33:12.11		more quickly than it is cleared out of the body.
00:33:14.21		And after many years of experimentation,
00:33:17.21		we finally concluded that the Staudinger ligation was just too slow.
00:33:23.11		Its kinetics were too slow compared to its rate of metabolism.
00:33:27.22		And it probably didn't help the situation that phosphines, in general,
00:33:32.25		can be oxidized in the mammalian liver
00:33:35.15		by cytochrome P450 enzymes.
00:33:37.05		which convert the phosphine to a phosphine oxide
00:33:42.08		and once that occurs, now this product
00:33:45.08		is no longer active in a Staudinger ligation.
00:33:47.08		So, undoubtedly, liver metabolism of the phosphine
00:33:51.19		contributed to its rapid clearance rate
00:33:54.23		which just out competed the intrinsically slow kinetics of the reaction.
00:33:58.23		So the bottom-line is that the Staudinger ligation
00:34:02.04		was great for in vitro imaging on cells in culture.
00:34:06.00		Not so great for in vivo imaging in live organisms
00:34:10.00		that have the ability to clear reagents rapidly out of the system.
00:34:13.20		So at that point we shifted our attention
00:34:17.19		to a different kind of chemistry that azides can undergo.
00:34:21.16		It's another chemistry that has its origins in the last century
00:34:26.03		in the hands of a German chemist.
00:34:27.28		In this case, Rolf Huisgen, Professor at University of Munich.
00:34:31.26		who back in the 1950s discovered that azides
00:34:35.26		can react with alkynes, undergo a 1,3-dipolar
00:34:41.07		cycloaddition reaction whose mechanism is shown here,
00:34:44.19		to form a cyclo adduct product called a triazole.
00:34:49.00		Now like the Staudinger chemistry,
00:34:52.04		this Huisgen cycloaddition chemistry
00:34:55.02		is bioorthogonal in that alkynes and azides
00:35:00.08		both are not found in biological systems,
00:35:03.04		at least not in most biological systems
00:35:05.06		and they react with each other very selectively
00:35:08.25		without any unwanted side reactions in the living system.
00:35:13.19		So we thought this would be another very promising avenue to explore.
00:35:16.25		The problem is that the classic Huisgen reaction
00:35:21.09		as described with a standard linear alkyne
00:35:24.27		is also very slow. In fact, even slower
00:35:28.11		than the Staudinger chemistry with phosphines.
00:35:30.28		So slow, that when people perform
00:35:34.22		these  reactions in a research laboratory,
00:35:37.04		they usually have to apply elevated temperatures
00:35:40.03		or elevated pressures in order to get the reaction
00:35:43.08		to proceed to completion at a reasonable rate.
00:35:45.26		And when I say elevated temperatures,
00:35:47.22		I mean above 100 degrees centigrade for example.
00:35:51.19		So refluxing toluene.  Hotter than the boiling temperature of water.
00:35:56.27		Obviously we can't do that to cells
00:36:00.14		and certainly not to living organisms.
00:36:02.14		But we started thinking about ways that we might be able to
00:36:05.18		accelerate the rate of this chemistry.
00:36:08.21		It turns out, back in the 1960s,
00:36:11.19		there was a publication by Wittig and Krebs
00:36:14.25		in which they reported that phenylazide reacts with
00:36:20.08		cyclooctyne which has a triple bond crimped into an eight-member ring
00:36:26.03		to form the triazole product very rapidly.
00:36:30.16		Now my graduate students were reading this paper.
00:36:33.25		It was published in German,
00:36:35.29		and unfortunately at that time we did not have
00:36:38.25		any coworkers in the laboratory whose German was good enough
00:36:41.18		to really understand the paper in its fine detail.
00:36:44.06		but all of us read this sentence
00:36:46.08		and recognized three words: phenylazide, cyclooctyne, and explosion.
00:36:53.02		So as far as we could see, Wittig and Krebs
00:36:57.14		had combined these two reagents
00:36:59.12		and they formed a product like an explosion.
00:37:02.11		which suggested to us that this must be a pretty fast reaction.
00:37:05.17		Keep in mind however, that what Wittig and Krebs did
00:37:09.05		is to react neat cyclooctyne,
00:37:12.03		which is a liquid, with neat phenylazide with no solvent.
00:37:17.05		So these were very concentrated reagents that reacted like an explosion.
00:37:20.09		And we figured, if we dissolve these reagents at lower concentrations
00:37:25.08		and prototypical solvents, maybe the reaction
00:37:28.07		will be very nicely controlled,
00:37:29.19		hopefully still very rapid at room temperature.
00:37:32.13		Now why you might ask does cyclooctyne
00:37:36.06		react with an azide like an explosion whereas
00:37:39.00		linear alkynes are so slow that you have to
00:37:42.17		heat them up above 100 degrees?
00:37:44.05		That can be understood by looking at what happens
00:37:47.27		to an alkyne when you force it into an eight membered ring.
00:37:51.13		Now normally, alkynes are linear.
00:37:54.12		That is their preferred geometry.
00:37:56.08		And when an alkyne reacts with an azide, this bond angle
00:38:00.28		is going from 180 degrees down to 120 degrees in the triazole product.
00:38:07.02		So that bond deformation costs a lot of energy
00:38:11.01		in the transition state for the reaction.
00:38:12.29		That's why we have to heat it up.
00:38:14.24		To give some of that energy to get over that activation barrier.
00:38:17.23		By contrast, if the alkyne is embedded in an eight membered ring
00:38:23.04		now the bond angle is bent to 160 degrees
00:38:27.25		It's not ideal, in fact, it costs a lot of strain
00:38:31.19		to bend a triple bond to 160 degrees
00:38:35.16		But the upshot is that now the difference
00:38:38.13		between 160 degrees and 120 degrees is quite a bit smaller.
00:38:42.06		It doesn't cost as much energy to go
00:38:44.09		from this structure through a transition state
00:38:46.22		to get to this product.
00:38:48.03		So our hope was that by straining the starting material
00:38:52.12		and bending the bond angle so it's closer
00:38:54.25		to the structure of the transition state
00:38:56.17		we would lower the activation barrier
00:38:58.24		so that the reaction can proceed at room temperature.
00:39:01.13		And that's exactly what we observed when we chemically synthesized
00:39:05.17		a whole family of cyclooctynes in the laboratory.
00:39:09.16		So let me just quickly summarize some kinetic comparisons
00:39:14.10		that we performed using a variety of synthetic reagents.
00:39:19.10		And so each of these compounds is a cyclooctyne
00:39:22.16		of some sort in some cases with a heteroatom in the ring
00:39:26.20		with various different substituents at different sites
00:39:29.12		and we made these compounds for a variety of reasons
00:39:32.21		that I won't go into.
00:39:33.13		but you'll see in some cases there were sp2 hybridized carbons
00:39:37.11		elsewhere in the ring.  Our hope was that we could increase the strain
00:39:41.15		energy a little bit more by putting
00:39:43.16		sp2 hybridized carbons in there.
00:39:46.01		And some of these reagents
00:39:47.03		have electronegative fluorine substituents.
00:39:49.27		which we also though might accelerate the reaction
00:39:53.01		based on some frontier molecular orbital arguments.
00:39:56.12		Also shown among this collection is a phosphine reagent
00:40:00.17		which is set up to a Staudinger ligation.
00:40:03.03		What we did is we took each of these compounds.
00:40:06.07		We reacted each compound with benzyl azide
00:40:09.27		in a test tube. And then we measured the
00:40:12.12		second order rate constant of the reaction.
00:40:14.26		And in blue are shown basically the relative values that we measured.
00:40:19.24		So the bottom-line is that we found a compound
00:40:24.03		that reacts very rapidly with azides in a test tube.
00:40:28.15		This is a di-fluorinated cyclooctyne
00:40:32.00		that we have given the abbreviation DIFO.
00:40:34.22		So that's stands for Di-Fluoro Cyclo Octyne.
00:40:39.00		DIFO. And the relative rate of reaction of DIFO
00:40:42.26		compared to some other compounds you'll see,
00:40:45.17		for example a compound without the fluorine atoms.
00:40:48.02		is very high. So we can accelerate the rate 75 fold
00:40:52.10		just by putting some fluorine atoms here
00:40:54.29		compared to some parent compounds.
00:40:57.08		Importantly, if you compare the relative rate of reactivity
00:41:00.08		between DIFO compared to a Staudinger ligation phosphine,
00:41:03.06		you will see that it is a good 15 times faster.
00:41:06.20		And so we felt that where the Staudinger ligation
00:41:09.26		failed in vivo because of its slow kinetics.
00:41:13.02		we might find success now with DIFO
00:41:16.11		as a reactive counterpart to the azide.
00:41:20.01		So we tested that concept in  a variety of imaging experiments
00:41:25.15		starting simply with cultured HeLa cells.
00:41:28.15		So remember, in a previous slide, I showed you
00:41:31.02		some images of the sialic acids on HeLa cells
00:41:34.26		where we reacted the azides with QPhos.
00:41:37.19		This is now a very similar experiment but
00:41:41.10		once we put the azides into the sialic acids
00:41:43.24		this time we react the azides with this compound.
00:41:48.05		So we call this DIFO-488.
00:41:51.00		Down here is the DIFO part, the di-fluoro cyclooctyne,
00:41:55.23		The green part of the molecule is a commercial
00:41:58.22		fluorescent dye called Alexafluor 488.
00:42:01.23		It's a bit like fluorescein in its spectral properties.
00:42:05.02		That is why we call this DIFO-488.
00:42:07.22		So what you are looking at here are the cultured HeLa cells.
00:42:11.19		They have been fed ManNAz to put azides into the sialic acids.
00:42:16.05		Then they were reacted with DIFO-488
00:42:19.03		and you can see that the sialic acids are shown in these nice
00:42:22.02		bright green halos around each cell.
00:42:24.10		The membranes are nicely lit up.
00:42:26.20		Those are the sialic acids.
00:42:28.06		This is a control experiment
00:42:30.12		in which instead of feeding the cells ManNAz,
00:42:33.27		we now fed them the natural sugar, ManNAc.
00:42:36.28		There are no azides in these cells.
00:42:39.20		We also reacted them with DIFO-488.
00:42:43.08		And now you don't see any green labeling of the membranes.
00:42:47.01		That is because there are no azides for DIFO to react with.
00:42:50.09		That's a testament to the selectivity of DIFO.
00:42:54.06		It only reacts with azides.
00:42:55.26		If there are no azides around, there is nothing for it to react with.
00:42:58.14		You don't see the sugars.
00:43:00.11		But the most important number on this slide
00:43:03.02		is this one right here.
00:43:05.09		Now we can see a beautiful image like this
00:43:07.17		by reacting the cells for less than 1 minute with DIFO-488.
00:43:13.02		Whereas in the previous experiment with QPhos,
00:43:16.10		the Staudinger ligation reagent,
00:43:18.20		we had to react the cells for over two hours.
00:43:22.02		If we can get this kind of an image within a minute,
00:43:25.22		I think now we can image the sugars in living animals.
00:43:29.28		This reaction is fast enough, so we hoped.
00:43:32.24		So, what animal model would one want to use to image the sugars?
00:43:38.17		Mice are obviously a very attractive model because one can
00:43:42.17		study a variety of human diseases in that model organism
00:43:46.04		including cancer. However, mice are not ideal for optical imaging,
00:43:50.15		because, as you know they are not transparent.
00:43:53.18		They are opaque.
00:43:54.20		One can do fluorescence imaging inside a  mouse,
00:43:57.15		but it requires a specific kind of dye, generally a near infrared dye.
00:44:02.06		and it's a more complicated experiment.
00:44:04.19		And for a first attempt at in vivo optical imaging,
00:44:08.23		we thought we would use a model organism
00:44:11.02		that is a little friendlier to an optical microscope.
00:44:14.04		And the obvious choice was the zebrafish.
00:44:18.03		So zebrafish are translucent.
00:44:20.09		You can see right through them
00:44:21.24		and monitor their organs in vivo.
00:44:24.10		in the live animal. Also, zebrafish
00:44:27.16		are a very attractive model for vertebrate developmental studies.
00:44:31.29		They have all the same organs and parts that we have.
00:44:35.23		They are vertebrates. And their embryonic
00:44:38.04		developmental program has been very well characterized.
00:44:42.10		So we know what zebrafish embryos
00:44:43.28		should look like at virtually all stages of their development.
00:44:48.00		We also know that there are changes in the glycome.
00:44:51.29		that correspond with embryonic development.
00:44:55.05		And so we though this was a very nice organism
00:44:57.06		to first of all test our chemical tools,
00:44:59.25		but second of all we might be able to address
00:45:02.22		some very interesting fundamental questions
00:45:04.25		of how the glycome changes during development.
00:45:07.15		And learn something about the field of glycobiology.
00:45:10.06		So, we started with some proof of concept experiments.
00:45:14.09		in which we focused not on sialic acid
00:45:17.06		but rather on a sugar called N-acetylgalactosamine.
00:45:22.05		abbreviated GalNAc for short.
00:45:24.12		The reason we were so interested
00:45:26.11		in GalNAc is because, as I mentioned in my first lecture,
00:45:30.17		it's the conserved core residue in a family
00:45:34.09		of O-linked glycans that are associated
00:45:37.14		with glycoproteins from the mucin family.
00:45:41.10		Mucins are a general class of glycoproteins
00:45:44.29		that are characterized by having dense clusters
00:45:47.29		of these O-linked glycans along the polypeptide backbone.
00:45:52.10		They're involved in cell adhesion,
00:45:54.10		regulating cell-cell interactions, and they are known
00:45:57.24		to be both developmentally regulated
00:45:59.15		and sometimes upregulated during malignant transformation.
00:46:03.13		So the mucins are an interesting class of glycoproteins.
00:46:07.13		They all have a GalNAc residue at their core position.
00:46:10.28		So we thought if we could introduce an azide
00:46:13.03		into this GalNAc residue perhaps we could image the mucins
00:46:18.20		in vivo. And the way we do that is to
00:46:21.23		simply feed cells, or in this case, zebrafish embryos,
00:46:25.23		This azido-acetyl derivative that we call GalNAz
00:46:30.14		once again, the hydroxy groups are protected with acetyl esters.
00:46:34.13		So that the compound can penetrate cell membranes
00:46:37.08		and inside the cell the acetyl groups are removed by esterases.
00:46:41.07		in vivo. Okay. So this was one of our first experiments
00:46:46.00		we performed to simply ask the question will zebrafish embryos
00:46:50.02		metabolize GalNAz and introduce it into the mucins,
00:46:54.09		and if so, can we then tag the azides
00:46:57.05		with DIFO reagents and image that sugar in vivo.
00:47:01.27		So in this experiment we fertilized zebrafish embryos in a test tube
00:47:06.05		and we added GalNAz to the culture media
00:47:09.27		and just let them develop over the course
00:47:11.28		of several days and then after about five days
00:47:15.11		we took the five day old zebrafish larvae
00:47:19.23		and we reacted it with DIFO linked to a fluorescent dye,
00:47:23.23		in this case it was DIFO-488,
00:47:25.24		the same compound I showed on the previous slide
00:47:28.06		and then we put those labeled zebrafish in a fluorescence microscope
00:47:33.00		and we took a picture. So what you are
00:47:35.14		looking at here is the labeled zebrafish
00:47:39.03		five days old, treated just as shown
00:47:41.14		in this schematic. And wherever you see any brightness
00:47:44.27		basically you are looking at the DIFO label
00:47:48.09		which has been covalently attached to the azido sugar.
00:47:52.00		There's also a five day old zebrafish in this panel.
00:47:55.01		You can't see it, I realize.
00:47:56.25		The reason is that the only difference
00:47:58.24		is that this zebrafish embryo developed in  the presence of
00:48:01.28		the natural sugar GalNAc, which has no azides.
00:48:05.16		So when we reacted this five day old zebrafish with DIFO-488,
00:48:10.06		there was nothing for the dye to react with
00:48:12.08		so you don't see any fluorescence.
00:48:13.14		Again it testifies to the exquisite selectivity of DIFO
00:48:18.13		for the azide. So basically this experiment
00:48:21.28		demonstrated to us that we can in fact image
00:48:25.03		those GalNAz residues in a live zebrafish.
00:48:29.20		And I should point out that these zebrafish
00:48:32.10		look perfectly normal, perfectly healthy
00:48:34.16		and happy, despite that fact that some fraction
00:48:37.11		of their GalNAc residues were replaced with GalNAz,
00:48:40.14		and that some fraction of those GalNAz residues
00:48:43.29		were chemically reacted with the DIFO reagent.
00:48:47.10		These zebrafish were then released back into their tanks,
00:48:50.17		and they go on to live a normal life as far as we can see.
00:48:53.22		So it doesn't appear to be harmful to the organism
00:48:56.06		which is important if the goal is to learn something
00:48:58.16		about the organism's fundamental biology.
00:49:01.16		We can also do experiments
00:49:03.18		where we probe for changes in the glycome,
00:49:06.03		as a function of time
00:49:07.27		which again, is one of the most interesting
00:49:10.01		aspects of the field of glycobiology.
00:49:11.27		For example, here is an experiment in which we took
00:49:16.02		a zebrafish embryo fertilized in culture
00:49:18.15		We add to the culture media GalNAz,
00:49:21.22		and we let those embryos develop in the presence of the azido sugar
00:49:25.17		Now, at a given time point,
00:49:28.01		we will take those embryos out of the media
00:49:30.15		rinse them off, and react them
00:49:33.11		with DIFO conjugated to a red fluorescent dye.
00:49:36.26		In this case it was Alexafluor 647.
00:49:40.09		Now some glycoproteins, those that were labeled
00:49:44.08		with azides now appear red,
00:49:46.16		but we can take those same embryos
00:49:47.25		that are carrying a fluorescent probe
00:49:49.21		and just put them back in media
00:49:51.09		and let them continue their developmental program.
00:49:54.04		What we do first is a 10 minute reaction
00:49:56.19		with a reagent called TCEP,
00:49:58.16		this is tricarboxydiethylphosphine.
00:50:01.05		What this reagent does is it reduces any
00:50:05.01		unreacted azides to the corresponding amine.
00:50:07.11		And incidentally the chemistry by which TCEP
00:50:10.17		reduces those unreacted azides
00:50:12.16		is classic Staudinger chemistry.
00:50:15.10		We are able to take advantage of that.
00:50:17.25		So we just destroy any unreacted azides.
00:50:20.08		We take these red labeled embryos,
00:50:22.16		put them back into the media containing GalNAz,
00:50:26.03		They continue to develop.
00:50:27.06		They take up more GalNAz as they are doing so.
00:50:29.21		And they'll integrate GalNAz into the next
00:50:32.26		wave of mucin glycoproteins.
00:50:35.06		And now we can take the embryos out
00:50:37.18		and label them again, this time with DIFO
00:50:40.03		conjugated to a green fluorescent dye.
00:50:42.16		So now, at the end of all of this,
00:50:44.29		there are two fluorescent dyes on the zebrafish.
00:50:48.13		The green dye reflect these azides that are
00:50:52.13		in glycoproteins biosynthesized most recently.
00:50:55.11		Whereas the red dye reflects the older population
00:50:58.18		of glycoproteins that were introduced earlier in development.
00:51:02.17		So this allows us to separate old glycoproteins from new glycoproteins
00:51:07.18		based on the color that they appear in the fluorescence microscope.
00:51:11.07		So that kind of an experiment is what led to images like this one
00:51:16.13		which I showed on the very first slide of this second lecture.
00:51:19.13		So this is the head of a 5 day old zebrafish
00:51:24.19		that has been labeled with GalNAz,
00:51:26.24		followed by three different colored fluorescent dyes
00:51:30.11		at three different time points.
00:51:31.17		In this particular image the newest glycoproteins
00:51:35.16		are appearing red, and you can see there's
00:51:37.11		a concentration of those glycoproteins
00:51:39.16		here in the olfactory organs,
00:51:41.22		which are basically the nostrils of the zebrafish.
00:51:45.05		Whereas older populations of glycoproteins appear either blue or green.
00:51:51.03		And you can see that the blue and the green
00:51:52.21		have quite a different distribution from the red.
00:51:55.10		And by looking at how these different colors
00:51:57.14		have moved around as a function of time,
00:51:59.26		we can learn something about the dynamics of the glycome.
00:52:04.02		At least from the perspective of these mucin glycoproteins
00:52:06.27		that we have labeled with GalNAz.
00:52:09.00		In fact one can use a confocal microscope to walk around
00:52:14.05		the labeled organism cell by cell
00:52:15.29		and take a very close look at what has happened
00:52:19.04		to the mucins as a function of time during the development.
00:52:22.21		Just for example, here is a panel of epithelial cells
00:52:26.16		and you can see that each epithelial cell looks as if it has
00:52:29.12		a red labeled membrane with blue and green puncta inside the cell.
00:52:34.26		Which is exactly what we would expect,
00:52:36.27		because in this experiment the red labeling
00:52:40.13		reflects the newest population of glycoproteins.
00:52:43.23		Those are the glycoproteins that just
00:52:45.18		emerged on the plasma membrane
00:52:47.08		with azides ready for us to label.
00:52:49.13		By contrast, older populations of glycoproteins
00:52:52.29		that were biosynthesized many hours before
00:52:55.15		we took this picture, they've already been recycled.
00:52:58.08		by endocytic vesicles in the membrane.
00:53:01.18		And that is why they appear inside the cell.
00:53:04.09		This is a structure that was rather dramatic
00:53:07.09		that appeared at around the 72 hour mark post fertilization.
00:53:12.11		What you are looking at here is a red projection
00:53:14.12		that is basically coming out of the screen
00:53:16.15		at you from the junction of three epithelial cells.
00:53:20.25		That red structure is a mechanosensory hair structure.
00:53:24.22		These are structures that protrude from the side
00:53:27.23		of the head of the embryo,
00:53:29.09		as you can see in this larger scale view.
00:53:32.06		These are structures that
00:53:33.19		the zebrafish can use to sense the flow of current in its environment.
00:53:36.28		for example.
00:53:38.20		And the fact that we captured this structure so dramatically in red
00:53:41.21		tells us first of all that it must contain these mucin like glycoproteins
00:53:47.29		otherwise we wouldn't be able to see it
00:53:49.23		because that is what we are imaging.
00:53:51.29		Secondly, that the majority of those glycoproteins
00:53:54.24		were formed within the window between
00:53:56.23		72 and 73 hours post-fertilization.
00:53:59.27		Which would be a very difficult window to capture
00:54:02.18		using other classic imaging technologies.
00:54:06.01		So these are the kinds of studies that are basically opening the window
00:54:10.01		through the vision of sugars into developmental biology.
00:54:14.10		And I think this is a very interesting
00:54:16.04		future application of the technology.
00:54:17.27		So what should you take home from this second lecture
00:54:23.02		in this series. First of all, there is a chemical lesson here,
00:54:26.11		which really has nothing to do with sugars.
00:54:28.15		It's the fact that, you know, we've taken advantage
00:54:31.13		of some very classic chemical tools.
00:54:34.08		These are chemical reaction that were first reported
00:54:37.20		as early as 1915.  That is almost one hundred years ago.
00:54:41.15		And these old classic chemistries: the Staudinger chemistry
00:54:44.29		and the Huisgen cycloaddition chemistry
00:54:46.23		we have found to be real gems for modern applications in biology.
00:54:52.22		So by digging into the old chemical literature,
00:54:55.29		one can find some incredible tools
00:54:58.17		to bring forth into the modern era of biological research.
00:55:02.09		And that's very exciting for someone who was trained as a chemist
00:55:05.15		and at heart considers herself a chemist.
00:55:08.17		Secondly, you should remember the azide.
00:55:11.11		The azide has phenomenal properties
00:55:15.00		that make it so well suited for these applications
00:55:18.15		as chemical reporters.
00:55:19.25		And we think that the azide
00:55:21.13		has a lot of potential not just for imaging sugars,
00:55:24.09		the way that we do it, but for imaging
00:55:26.11		all kinds of interesting biomolecules.
00:55:28.26		including proteins, lipids, nucleic acids,
00:55:32.12		metabolites, things that are not necessarily encoded in the genome,
00:55:37.08		for which the GFP and other genetic reporters are really not well suited.
00:55:43.11		Third we now have shown that metabolic labeling with azido sugars
00:55:48.22		allows you to image the glycans in living systems.
00:55:51.23		And we think this will allow scientists
00:55:53.29		to study glycobiology using all of the hardware of molecular imaging
00:55:59.28		that so far has focused primarily on the study of proteins.
00:56:04.11		And finally, where we are going with this technology in my laboratory
00:56:10.04		is to continue our studies of developmental biologies
00:56:12.19		until we can understand how the glycome contributes
00:56:15.11		to some of the early cell fate decision making processes
00:56:18.12		during the embryogenic program.
00:56:20.10		For example, how does the glycome change
00:56:22.18		when pluripotent embryonic stem cells are just starting
00:56:27.12		to choose their ultimate differentiation fate.
00:56:30.06		We are hoping that we can capture a snapshot
00:56:32.22		of that moment from the perspective of the glycome.
00:56:35.20		And then finally, you know, one of our original motivations
00:56:38.27		was to develop these tools in a manner that
00:56:41.22		could be clinically useful. So we are hoping that
00:56:44.29		we can develop the chemical reagents
00:56:47.09		the azido-sugars in such a manner that you could
00:56:50.18		actually introduce these reagents into human subjects.
00:56:54.01		And use them to detect tumors at early stages
00:56:57.06		by virtue of their changing glycome.
00:57:00.01		So stay tuned, and hopefully we will have a lot more to say
00:57:03.02		about that in the future.
00:57:04.20		Finally I'd like to acknowledge the students
00:57:08.26		and postdoctoral fellows in my laboratory.
00:57:10.21		What you are seeing on this slide
00:57:12.17		is a snapshot of my laboratory at this particular moment in time
00:57:16.21		where I am showing you all of the students
00:57:19.02		and postdocs who are presently in the lab
00:57:20.25		although I have listed just a small list of  alumni
00:57:24.10		whose work I alluded to during this lecture.
00:57:27.27		Most of their names were actually mentioned on the slides
00:57:30.19		along with reference to publications if you are interested in
00:57:33.10		digging into this in more gory detail.
00:57:36.07		But it should be said that all of the work that I presented
00:57:39.04		from my laboratory is in fact the hands-on research
00:57:43.10		of my students and postdoctoral fellows and I am
00:57:46.27		largely the mouthpiece that has the privilege of sharing this with the world.
00:57:50.29		So, thank you very much for tuning in, and I hope you enjoyed learning a little bit
00:57:55.04		about chemical glycobiology.

This material is based upon work supported by the National Science Foundation and the National Institute of General Medical Sciences under Grant No. 2122350 and 1 R25 GM139147. Any opinion, finding, conclusion, or recommendation expressed in these videos are solely those of the speakers and do not necessarily represent the views of the Science Communication Lab/iBiology, the National Science Foundation, the National Institutes of Health, or other Science Communication Lab funders.

© 2023 - 2006 iBiology · All content under CC BY-NC-ND 3.0 license · Privacy Policy · Terms of Use · Usage Policy
 

Power by iBiology